Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 406816, 7 pages
http://dx.doi.org/10.1155/2014/406816
Research Article

Effects of Modified Simiao Decoction on IL-1β and TNFα Secretion in Monocytic THP-1 Cells with Monosodium Urate Crystals-Induced Inflammation

Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei 430030, China

Received 13 February 2014; Revised 13 May 2014; Accepted 16 May 2014; Published 5 June 2014

Academic Editor: Bashar Saad

Copyright © 2014 Ya-Fei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. Abbott, F. N. Brand, W. B. Kannel, and W. P. Castelli, “Gout and coronary heart disease: the Framingham Study,” Journal of Clinical Epidemiology, vol. 41, no. 3, pp. 237–242, 1988. View at Google Scholar · View at Scopus
  2. K. R. Hande, R. M. Noone, and W. J. Stone, “Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency,” American Journal of Medicine, vol. 76, no. 1, pp. 47–56, 1984. View at Google Scholar · View at Scopus
  3. S. N. Ramasamy, C. S. Korb-Wells, D. R. Kannangara, M. W. Smith, N. Wang, and D. M. Roberts, “Allopurinol hypersensitivity: a systematic review of all published cases, 1950–2012,” Drug Safety, vol. 36, no. 10, pp. 953–980, 2013. View at Google Scholar
  4. J. Z. Singer and S. L. Wallace, “The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality,” Arthritis & Rheumatism, vol. 29, no. 1, pp. 82–87, 1986. View at Google Scholar · View at Scopus
  5. Y. Finkelstein, S. E. Aks, J. R. Hutson et al., “Colchicine poisoning: the dark side of an ancient drug,” Clinical Toxicology, vol. 48, no. 5, pp. 407–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Giouroukakis and M. Dryer, “Unapproved drugs—the drug information pharmacists' perspective,” Journal of Pharmacy Practice, vol. 26, no. 2, pp. 112–119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Hua, P. Huang, C. M. Zhu, X. Yuan, and C. H. Yu, “Anti-hyperuricemic and nephroprotective effects of Modified Simiao Decoction in hyperuricemic mice,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 248–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. H. Hu, R. Q. Jiao, X. Wang, Y. Z. Lv, and L. D. Kong, “Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice,” Journal of Ethnopharmacology, vol. 128, no. 3, pp. 685–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. D. Kong, C. Yang, F. Ge, H. D. Wang, and Y. S. Guo, “A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice,” Journal of Ethnopharmacology, vol. 93, no. 2-3, pp. 325–330, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Shi, G. Li, Z. Qian, Z. Jin, and Y. Song, “Randomized and controlled clinical study of modified prescriptions of Simiao Pill in the treatment of acute gouty arthritis,” Chinese Journal of Integrative Medicine, vol. 14, no. 1, pp. 17–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Wang, C. P. Wang, Q. H. Hu et al., “The dual actions of Sanmiao wan as a hypouricemic agent: down-regulation of hepatic XOD and renal mURAT1 in hyperuricemic mice,” Journal of Ethnopharmacology, vol. 128, no. 1, pp. 107–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. W. H. Wollaston, “On gouty and urinary concretions. By william hyde wollaston, mdfrs,” Philosophical Transactions of the Royal Society of London, vol. 87, pp. 386–400, 1797. View at Google Scholar
  13. A. B. Garrod, “Observations on certain pathological conditions of the blood and urine, in gout, rheumatism, and bright's disease,” Medico-Chirurgical Transactions, vol. 31, pp. 83–97, 1848. View at Google Scholar
  14. R. C. Landis and D. O. Haskard, “Pathogenesis of crystal-induced inflammation,” Current Rheumatology Reports, vol. 3, no. 1, pp. 36–41, 2001. View at Google Scholar · View at Scopus
  15. S. R. Kingsbury, P. G. Conaghan, and M. F. McDermott, “The role of the NLRP3 inflammasome in gout,” Journal of Inflammation Research, vol. 4, no. 1, pp. 39–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Liu-Bryan, “Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome,” Immunology and Cell Biology, vol. 88, no. 1, pp. 20–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp, “Gout-associated uric acid crystals activate the NALP3 inflammasome,” Nature, vol. 440, no. 7081, pp. 237–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. F. S. di Giovine, S. E. Malawista, G. Nuki, and G. W. Duff, “Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblasts mitogenesis by urate crystal-induced IL 1,” Journal of Immunology, vol. 138, no. 10, pp. 3213–3218, 1987. View at Google Scholar · View at Scopus
  19. R. C. Landis, D. R. Yagnik, O. Florey et al., “Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages,” Arthritis & Rheumatism, vol. 46, no. 11, pp. 3026–3033, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. D. McGonagle, A. L. Tan, S. Shankaranarayana, J. Madden, P. Emery, and M. F. McDermott, “Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra,” Annals of the Rheumatic Diseases, vol. 66, no. 12, pp. 1683–1684, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Terkeltaub, J. S. Sundy, H. R. Schumacher et al., “The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study,” Annals of the Rheumatic Diseases, vol. 68, no. 10, pp. 1613–1617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Tsuchiya, Y. Kobayashi, Y. Goto et al., “Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester,” Cancer Research, vol. 42, no. 4, pp. 1530–1536, 1982. View at Google Scholar · View at Scopus
  23. Y. C. Meng, X. Ding, C. E. Ben, and S. G. Guo, “The application view of Chinese traditional medicine Serum Pharmacological,” Journal of Beijing University Traditional Chinese Medicine, vol. 22, no. 4, pp. 42–43, 1999. View at Google Scholar
  24. S. Tashino, “Serum pharmacology and serum pharmaceutical chemistry: from pharmacology of Chinese traditional medicines to start a new measurement of drug concentration in blood,” Therapeutic Drug Monitoring Research, vol. 5, pp. 54–64, 1988. View at Google Scholar
  25. H. Iwama, S. Amagaya, and Y. Ogihara, “Effect of Shosaikoto, a Japanese and Chinese traditional herbal medicinal mixture, on the mitogenic activity of lipopolysaccharide: a new pharmacological testing method,” Journal of Ethnopharmacology, vol. 21, no. 1, pp. 45–53, 1987. View at Google Scholar · View at Scopus
  26. W. Bochu, Z. Liancai, and C. Qi, “Primary study on the application of Serum Pharmacology in Chinese traditional medicine,” Colloids and Surfaces B: Biointerfaces, vol. 43, no. 3-4, pp. 194–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Tang, Z. Zhang, Y. Gao, Y. Wei, and L. Han, “Protective effects of serum containing Ginkgo biloba extract on glomerulosclerosis in rat mesangial cells,” Journal of Ethnopharmacology, vol. 124, no. 1, pp. 26–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. X. X. Li, M. Han, Y. Y. Wang, and J. P. Liu, “Chinese herbal medicine for gout: a systematic review of randomized clinical trials,” Clinical Rheumatology, vol. 32, no. 7, pp. 943–959, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Shi, L. Xu, Y. Yang, H. Song, H. Pan, and L. Yin, “Suppressive effect of modified simiaowan on experimental gouty arthritis: an in vivo and in vitro study,” Journal of Ethnopharmacology, vol. 150, no. 3, pp. 1038–1044, 2013. View at Google Scholar
  30. T. J. Coderre and P. D. Wall, “Ankle joint urate arthritis in rats provides a useful tool for the evaluation of analgesic and anti-arthritic agents,” Pharmacology Biochemistry and Behavior, vol. 29, no. 3, pp. 461–466, 1988. View at Google Scholar · View at Scopus
  31. T. J. Coderre and P. D. Wall, “Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freund's adjuvant,” Pain, vol. 28, no. 3, pp. 379–393, 1987. View at Google Scholar · View at Scopus
  32. M. A. Martillo, L. Nazzal, and D. B. Crittenden, “The crystallization of monosodium urate,” Current Rheumatology Reports, vol. 16, no. 2, pp. 1–8, 2014. View at Google Scholar
  33. H. M. Burt and Y. C. Dutt, “Crystallization of monosodium urate monohydrate,” Journal of Crystal Growth, vol. 94, no. 1, pp. 15–22, 1989. View at Google Scholar · View at Scopus
  34. W. R. Wilcox and A. A. Khalaf, “Nucleation of monosodium urate crystals,” Annals of the Rheumatic Diseases, vol. 34, no. 4, pp. 332–339, 1975. View at Google Scholar · View at Scopus
  35. C. M. Perrin, M. A. Dobish, E. Van Keuren, and J. A. Swift, “Monosodium urate monohydrate crystallization,” CrystEngComm, vol. 13, no. 4, pp. 1111–1117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. D. R. Yagnik, P. Hillyer, D. Marshall, C. D. Smythe, T. Krausz, and D. O. Haskard, “Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages: implications for the control of joint inflammation in gout,” Arthritis & Rheumatism, vol. 43, no. 8, pp. 1779–1789, 2000. View at Google Scholar
  37. H. Ye, P. Huang, H. Ying, and Q. Shou, “Influence of simiao bixie decoction on IL-1β, PGE2 of acute gouty arthritis,” Journal of Zhejiang University of Traditional Chinese Medicine, vol. 34, no. 2, pp. 158–162, 2010. View at Google Scholar
  38. G. Chen, R. Han, F. Gu, K. Cao, L. Li, and Y. Wang, “Protective effects of si-miao decoction on acute gouty arthritis induced by MSU in rabbits,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 14, no. 2, pp. 42–45, 2008. View at Google Scholar
  39. G. Chen, Y. Duan, L. Li, and H. Liu, “Experimental study of the protective effects and mechanisms of additional si-miao decoction on acute gouty arthritis and hyperuricemia,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 14, no. 3, pp. 48–52, 2008. View at Google Scholar